Showing 7951-7960 of 10737 results for "".
Improving Adherence to Topical Regimens
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/improving-adherence-to-topical-regimens/48780/Zoe Diana Draelos, MD, discusses strategies for improving adherence to topical regimens in chronic atopic dermatitis.The Case for Prioritizing Patient Reacquisition
https://practicaldermatology.com/videos/c-suite-chats/the-case-for-prioritizing-patient-reacquisition/56424/Susie Kozlowski, Business Development Manager for Brevium, explains the importance of patient reacquisition for a dermatology practice.The War Zone: Private Practice
https://practicaldermatology.com/podcasts/the-practical-dermatology-podcast/the-war-zone-private-practice/54847/The War Zone: Private PracticePractical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Editorial Board member Collin Blattner, DO, FAAD, discuss strategies for building a successful private practice in the era of private equity, as well as the challenges associated with it.Dermwire TV: Topical Caffeine for Hair Growth, Tapinarof for Pediatric AD
https://practicaldermatology.com/videos/dermwire-tv/dermwire-tv-topical-caffeine-for-hair-growth-tapinarof-for-pediatric-ad/48734/This episode highlights studies showing potential for topical caffeine in hair growth in patients with alopecia areata, as well as recent positive results for tapinarof cream 1% for children with AD. Also, Cutera CEO Taylor Harris talks with Practical Dermatology about the evolving needs of today’sPDRN and Regenerative Medicine Update
https://practicaldermatology.com/conferences/science-of-skin-summit-2025/pdrn-regenerative-medicine-update/39739/Suneel Chilukuri, MD, covers the latest in polydeoxyribonucleotide (PDRN) therapies and regenerative medicine applications in dermatology. This video was recorded at the Science of Skin Summit in Austin, TX.DermwireTV: FDA Clears Roflumilast, Guselkumab for Pediatric Populations, Plus More
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-fda-clears-roflumilast-guselkumab-for-pediatric-populations-plus-more/39732/This episode highlights two new important pediatric approvals for treatments in both atopic dermatitis and psoriatic disease, also features a clip from a recent YoungMD Connect (YMDC) mentorship session with Dr. Tina Bhutani covering both career paths in both academia and industry.Increased APS Risk for Psoriasis Patients, Plus More
https://practicaldermatology.com/videos/dermwire-tv/increased-aps-risk-for-psoriasis-patients-plus-more/39299/This episode highlights research showing increased risk for anti-phospholipid syndrome (APS) in patients with psoriatic disease, as well as research showing increased risks for tuberculosis in patients treated with immunosuppressants. The episode also features a clip from an in-depth discussion arouPsoriasis Therapeutics and Moving to Private Practice
https://practicaldermatology.com/podcasts/practical-dermatology-podcasts/program-name/35733/H.L. Greenberg, MD, discusses his recent Practical Dermatology article on the various benefits of different psoriasis therapeutics, and Tina Bhutani, MD, MAS, FAAD, joins Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, to discuss the transition from academia to private practice and playFDA Grants Interchangeability to HADLIMA
https://practicaldermatology.com/videos/dermwire-tv/fda-grants-interchangeability-to-hadlima/35962/In this week's DermwireTV, the FDA grants full interchangeability to HADLIMA; new research shows the impact of UV exposure on global skin cancer cases; and coverage from Music City SCALE addresses barriers to patient access to new therapies.When and How to Use Ancillary Testing
https://practicaldermatology.com/programs/practical-dermatology-updates-in-skin-cancer/when-and-how-to-use-ancillary-testing/35598/Hadas Skupsky, MD, a board-certified dermatologist and dermatopathologist, discusses when a dermatopathologist decides to use ancillary testing for melanoma, how that impacts final diagnosis, and how it can guide treatment decisions.